unitedhealth

Stable11 articles7 sourcesDernière mise à jour: 20/07/2026

Sujets associésmurder trial Luigi Mangione Brian Thompson UnitedHealthcare earnings medical costs profit outlook luigi mangione

Derniers articles

UnitedHealth Group Beats Earnings Estimates, Raises Profit Outlook Amid AI Integration

DERNIÈRE MINUTE

Business·20/07/2026Résumé IA

UnitedHealth Group Beats Earnings Estimates, Raises Profit Outlook Amid AI Integration

UnitedHealth Group exceeded second-quarter earnings estimates and increased its full-year profit outlook, driven by improved management of high medical costs and a significant $1.5 billion investment in AI to streamline operations. The company's stock jumped over 7% on the news, despite ongoing elevated medical costs and membership declines.

CNBC US Markets

4 min de lecture

UnitedHealth's HouseCalls Unit Audit Finds 97% of Diagnoses Supported by Records

En développement

Business·07/07/2026Résumé IA

UnitedHealth's HouseCalls Unit Audit Finds 97% of Diagnoses Supported by Records

An external audit of UnitedHealth's HouseCalls unit found 97% of diagnoses were supported by patient records. The audit, commissioned by UnitedHealth, addressed scrutiny from lawmakers over diagnoses not appearing elsewhere in patient histories, which influence Medicare Advantage payments. 3.4% of diagnoses lacked support.

The Independent World

Luigi Mangione's Federal Trial in UnitedHealthcare CEO Killing Postponed to January

En développement

Crime·30/06/2026Résumé IA

Luigi Mangione's Federal Trial in UnitedHealthcare CEO Killing Postponed to January

Luigi Mangione's federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January 2025, allowing his lawyers to focus on his state murder trial scheduled for September. Mangione, who pleaded not guilty, faces federal charges for traveling across state lines to stalk and kill Thompson, and has publicly criticized the prospect of two trials as "double jeopardy."

The Independent World

3 min de lecture

Plea Deal Talks Collapse for Man Accused of Killing UnitedHealthcare CEO

En développement

Crime·26/06/2026Résumé IA

Plea Deal Talks Collapse for Man Accused of Killing UnitedHealthcare CEO

Plea deal discussions between federal prosecutors and lawyers for Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, have collapsed. Mangione, who pleaded not guilty to state and federal charges, faces trials in September and October, with the case sparking national debate on the U.S. health insurance system.

The Independent World

2 min de lecture

Mangione to use psychiatric defense in state murder trial

En développement

Crime·17/06/2026Résumé IA

Mangione to use psychiatric defense in state murder trial

Luigi Mangione plans to use an extreme emotional disturbance defense in his state murder trial for the killing of UnitedHealthcare CEO Brian Thompson. This defense could lead to a manslaughter conviction instead of murder, potentially reducing his prison sentence. A federal case against Mangione is separate and does not allow this defense.

Euronews News

4 min de lecture

Luigi Mangione's defense to argue psychiatric defense in Brian Thompson murder trial

En développement

Crime·17/06/2026Résumé IA

Luigi Mangione's defense to argue psychiatric defense in Brian Thompson murder trial

Luigi Mangione's lawyers will argue a psychiatric defense in his state murder trial for the shooting death of UnitedHealthcare CEO Brian Thompson. Judge Gregory Carro will unseal court records related to the defense's plan, which aims to show Mangione suffered "extreme emotional disturbance" at the time of the incident.

BBC World

1 min de lecture

Luigi Mangione Murder Hearing Delayed Due to Prosecutor Error

En développement

Crime·16/06/2026Résumé IA

Luigi Mangione Murder Hearing Delayed Due to Prosecutor Error

A court hearing for Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, was delayed Tuesday because prosecutors failed to notify jail officials of his required transport. The hearing is rescheduled for Wednesday.

The Independent World

2 min de lecture

UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 High Quality Stocks to Buy According to Hedge Funds

ACTU

22/05/2026Résumé IA

UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 High Quality Stocks to Buy According to Hedge Funds

UnitedHealth Group (UNH) receives bullish analyst upgrades from UBS and BofA, with price targets raised to $460 and $420 respectively, driven by strong Q1 results and confidence in margin recovery.

Yahoo Finance

1 min de lecture

New York City Reviews Press Credentialing After 'Mangionistas' Controversy

En développement

Politique·21/05/2026Résumé IA

New York City Reviews Press Credentialing After 'Mangionistas' Controversy

New York City is reviewing its press credentialing process after three supporters of accused murderer Luigi Mangione, known as 'The Mangionistas,' were issued press passes and made controversial public remarks. Mayor Zohran Mamdani stated they should not have received passes, highlighting the difficulty in distinguishing legitimate journalists from influencers and activists.

NY Judge Blocks Evidence in Mangione Murder Trial

A New York judge has blocked prosecutors from using evidence found in Luigi Mangione's backpack during his murder trial, ruling it was not sufficiently in his control when detained. Items like a magazine, cellphone, passport, wallet, and computer chip were suppressed, though a journal can be used.

UnitedHealth Posts Strong Q1 Earnings, Raises 2026 Profit Outlook

UnitedHealth Group reported Q1 earnings of $7.23 per share, beating estimates of $6.57, with revenue of $111.72B. The company raised its 2026 profit outlook to over $18.25 per share, citing improved medical cost management and operational streamlining.

CNBC

2 min de lecture